Personal tools

MCL coexpression mm9:571: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002384!3.14e-17!46;UBERON:0002390!2.01e-16!45;UBERON:0003061!2.01e-16!45;UBERON:0002193!3.73e-15!48;UBERON:0002405!3.73e-15!48;UBERON:0002370!6.30e-15!23;UBERON:0000974!6.30e-15!23;UBERON:0004807!6.30e-15!23;UBERON:0005058!6.30e-15!23;UBERON:0003351!6.30e-15!23;UBERON:0009113!6.30e-15!23;UBERON:0003295!6.30e-15!23;UBERON:0009722!6.30e-15!23;UBERON:0005562!6.30e-15!23;UBERON:0007690!6.30e-15!23;UBERON:0006562!3.32e-14!24;UBERON:0003408!3.32e-14!24;UBERON:0001557!3.32e-14!24;UBERON:0001042!3.32e-14!24;UBERON:0008814!3.32e-14!24;UBERON:0009145!3.32e-14!24;UBERON:0000072!2.31e-12!27;UBERON:0004177!2.40e-11!29;UBERON:0005057!2.40e-11!29;UBERON:0000077!5.33e-09!35;UBERON:0000063!5.33e-09!35;UBERON:0007811!1.10e-08!36;UBERON:0003081!1.40e-07!87;UBERON:0000065!2.40e-07!41;UBERON:0001004!4.06e-07!42;UBERON:0000153!6.71e-07!43
|ontology_enrichment_uberon=UBERON:0002384!3.14e-17!46;UBERON:0002390!2.01e-16!45;UBERON:0003061!2.01e-16!45;UBERON:0002193!3.73e-15!48;UBERON:0002405!3.73e-15!48;UBERON:0002370!6.30e-15!23;UBERON:0000974!6.30e-15!23;UBERON:0004807!6.30e-15!23;UBERON:0005058!6.30e-15!23;UBERON:0003351!6.30e-15!23;UBERON:0009113!6.30e-15!23;UBERON:0003295!6.30e-15!23;UBERON:0009722!6.30e-15!23;UBERON:0005562!6.30e-15!23;UBERON:0007690!6.30e-15!23;UBERON:0006562!3.32e-14!24;UBERON:0003408!3.32e-14!24;UBERON:0001557!3.32e-14!24;UBERON:0001042!3.32e-14!24;UBERON:0008814!3.32e-14!24;UBERON:0009145!3.32e-14!24;UBERON:0000072!2.31e-12!27;UBERON:0004177!2.40e-11!29;UBERON:0005057!2.40e-11!29;UBERON:0000077!5.33e-09!35;UBERON:0000063!5.33e-09!35;UBERON:0007811!1.10e-08!36;UBERON:0003081!1.40e-07!87;UBERON:0000065!2.40e-07!41;UBERON:0001004!4.06e-07!42;UBERON:0000153!6.71e-07!43
|tfbs_overrepresentation_for_novel_motifs=0.244604,0.341626,0.223558,0.279403,0.138992,0.291576,0.968292,0.268276,0.59395,0.282547,0.331725,0.35958,0.567414,0.381063,0.898708,0,0.557619,0.133477,0.244912,0.119642,0.194751,0.0768335,0.38026,0.427399,0.229596,0.405649,0.501183,0.309422,0.171781,0.384773,0.297405,0.653099,0.131928,0.447379,0.151158,0.0412484,0.790102,0.356403,0.111088,0.309817,0.42301,0.301802,0.175756,0.463442,0.228983,0.270091,0.48361,0.322976,0.0503358,0.173974,1.3373,0.429887,0.366754,0.788877,0.805733,0.387424,0.18067,0.348382,0.0605105,0.385607,0.634076,0.438439,0.090369,0.5308,0.397364,0.568642,0.938213,1.28193,0.629645,1.13654,0.600538,0.277751,0.211975,0.838198,0.0571922,0.74965,0.447182,0.473159,0.617814,1.09058,0.279684,0.573903,1.95086,0.0742829,0.72691,0.0742036,0.0888017,0.0444451,0.488122,1.44275,1.0064,0.731688,0.665283,0.143149,0.108477,1.62017,0.0764965,0.667958,0.483845,0.329451,1.28682,1.5718,1.81917,0.541854,0.54087,0.301427,0.596902,0.855679,1.1054,0.196131,0.238877,0.773781,0.19888,0.336214,1.01331,0.41985,0.037872,0.282562,0.558838,0.389429,0.843435,0.511336,0.407285,0.472327,1.06644,0.621313,0.377415,0.658832,0.936732,0.445937,0.755703,0.273302,0.907893,0.399614,1.03449,0.0163629,0.251471,0.303003,0.986296,1.80931,1.41113,0.942814,1.07314,0.66306,0.53483,0.302189,0.486482,1.76978,0.253405,0.140226,0.173337,0.344099,0.790393,0.331601,0.398786,0.869538,1.10066,0.481451,0.680297,0.251242,0.995609,0.726089,0.621734,0.237049,0.531751,1.01654,0.786757,0.941787,0.085942
}}
}}

Revision as of 18:34, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr13:112597483..112597500,+p@chr13:112597483..112597500
+
Mm9::chr13:112768168..112768198,+p@chr13:112768168..112768198
+
Mm9::chr13:112774257..112774268,-p@chr13:112774257..112774268
-
Mm9::chr13:112774486..112774496,+p@chr13:112774486..112774496
+
Mm9::chr13:112791448..112791460,-p@chr13:112791448..112791460
-
Mm9::chr13:112791623..112791634,+p@chr13:112791623..112791634
+
Mm9::chr13:112792109..112792132,+p@chr13:112792109..112792132
+
Mm9::chr14:122338220..122338258,+p@chr14:122338220..122338258
+
Mm9::chr1:130487882..130487893,+p@chr1:130487882..130487893
+
Mm9::chr2:57091169..57091175,-p2@ENSMUST00000146529
p2@ENSMUST00000156418
p2@uc008jsa.1
Mm9::chr5:112705390..112705402,-p@chr5:112705390..112705402
-
Mm9::chr5:149827693..149827716,+p@chr5:149827693..149827716
+
Mm9::chr9:116084406..116084415,+p@chr9:116084406..116084415
+


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Cell Type
Ontology termp-valuen
hematopoietic cell1.55e-2632
hematopoietic oligopotent progenitor cell1.55e-2632
hematopoietic stem cell1.55e-2632
angioblastic mesenchymal cell1.55e-2632
hematopoietic multipotent progenitor cell1.55e-2632
hematopoietic lineage restricted progenitor cell2.84e-2425
lymphoid lineage restricted progenitor cell5.34e-2412
lymphocyte5.34e-2213
common lymphoid progenitor5.34e-2213
T cell3.78e-2111
pro-T cell3.78e-2111
nucleate cell1.70e-1716
connective tissue cell3.14e-1746
mesenchymal cell3.14e-1746
leukocyte2.38e-1617
nongranular leukocyte2.38e-1617
mature alpha-beta T cell2.38e-169
alpha-beta T cell2.38e-169
immature T cell2.38e-169
mature T cell2.38e-169
immature alpha-beta T cell2.38e-169
motile cell4.42e-1454
CD4-positive, alpha-beta T cell1.14e-138
megakaryocyte progenitor cell3.23e-126
megakaryocyte3.23e-126
stem cell3.62e-1097
common myeloid progenitor1.64e-0819
thymocyte1.64e-086
double negative thymocyte1.64e-086
naive T cell1.64e-086
double-positive, alpha-beta thymocyte1.64e-086
CD4-positive, alpha-beta thymocyte1.64e-086
naive thymus-derived CD4-positive, alpha-beta T cell1.64e-086
DN4 thymocyte1.64e-086
DN1 thymic pro-T cell1.64e-086
DN2 thymocyte1.64e-086
DN3 thymocyte1.64e-086
immature single positive thymocyte1.64e-086
early T lineage precursor1.64e-086
mature CD4 single-positive thymocyte1.64e-086
resting double-positive thymocyte1.64e-086
double-positive blast1.64e-086
CD69-positive double-positive thymocyte1.64e-086
CD69-positive, CD4-positive single-positive thymocyte1.64e-086
CD4-positive, CD8-intermediate double-positive thymocyte1.64e-086
CD24-positive, CD4 single-positive thymocyte1.64e-086
megakaryocyte-erythroid progenitor cell4.95e-089
somatic stem cell9.80e-0891
multi fate stem cell9.80e-0891

Uber Anatomy
Ontology termp-valuen
connective tissue3.14e-1746
hematopoietic system2.01e-1645
blood island2.01e-1645
hemolymphoid system3.73e-1548
immune system3.73e-1548
thymus6.30e-1523
neck6.30e-1523
respiratory system epithelium6.30e-1523
hemolymphoid system gland6.30e-1523
pharyngeal epithelium6.30e-1523
thymic region6.30e-1523
pharyngeal gland6.30e-1523
entire pharyngeal arch endoderm6.30e-1523
thymus primordium6.30e-1523
early pharyngeal endoderm6.30e-1523
pharynx3.32e-1424
gland of gut3.32e-1424
upper respiratory tract3.32e-1424
chordate pharynx3.32e-1424
pharyngeal arch system3.32e-1424
pharyngeal region of foregut3.32e-1424
segment of respiratory tract2.31e-1227
hemopoietic organ2.40e-1129
immune organ2.40e-1129
mixed endoderm/mesoderm-derived structure5.33e-0935
organ segment5.33e-0935
craniocervical region1.10e-0836
lateral plate mesoderm1.40e-0787
respiratory tract2.40e-0741
respiratory system4.06e-0742
anterior region of body6.71e-0743


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}